GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $31,000 | -89.9% | 1,288 | -93.9% | 0.00% | -100.0% |
| Q4 2020 | $307,000 | +14.6% | 21,008 | +15.1% | 0.00% | 0.0% |
| Q2 2020 | $268,000 | +6600.0% | 18,249 | +5983.0% | 0.00% | – |
| Q4 2016 | $4,000 | -89.7% | 300 | -93.9% | 0.00% | -100.0% |
| Q3 2015 | $39,000 | +457.1% | 4,900 | +521.8% | 0.00% | – |
| Q2 2015 | $7,000 | -74.1% | 788 | -65.0% | 0.00% | -100.0% |
| Q3 2013 | $27,000 | -22.9% | 2,250 | -32.8% | 0.00% | 0.0% |
| Q2 2013 | $35,000 | – | 3,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
| Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
| Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
| Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
| HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
| Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
| WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
| Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |